More cardiac studies for ultrasound agent:
This article was originally published in Clinica
Sonus Pharmaceuticals is to begin two further studies of its EchoGen ultrasound contrast agent in the US. The Phase II studies will assess the measurement of left ventricular volume in patients with suspected heart attacks who enter the emergency room with chest pain.
You may also be interested in...
Asking whether FDA’s decision to allow emergency use of two old anti-malarial drugs was ‘political’ misses the point. The issue already was political, and FDA’s action may well be the best way to keep some measure of federal control on supplies of a drug with important other uses.
Guidelines for health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.